DNAM-1 (CD226): A Two-Sword Fencer for Innate and Adaptive Immunity

Publisher： Bentham Science Publishers

E-ISSN： 1875-6131|4|1|53-58

ISSN： 1568-0142

Source： Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents, Vol.4, Iss.1, 2005-02, pp. : 53-58

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Influenza Virus NS1 Protein: Inhibitor of Innate and Adaptive Immunity

By  

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 7, Iss. 4, 2007-12 ,pp. : 336-343

Bentham Science Publishers

Access to resources Recommend Favorite

Defensin Participation in Innate and Adaptive Immunity

By  

Current Pharmaceutical Design, Vol. 13, Iss. 30, 2007-10 ,pp. : 3131-3139

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Manipulation of the Immune System: Enhancement of Innate and Adaptive Mucosal Immunity

By  

Current Pharmaceutical Design, Vol. 9, Iss. 24, 2003-09 ,pp. : 1965-1972

Bentham Science Publishers

Access to resources Recommend Favorite

CD93 and Related Family Members: Their Role in Innate Immunity

By  

Current Drug Targets, Vol. 9, Iss. 2, 2008-02 ,pp. : 130-138

Bentham Science Publishers

Access to resources Recommend Favorite

Influenza-induced innate immunity: regulators of viral replication, respiratory tract pathology & adaptive immunity

By Oslund Karen L   Baumgarth Nicole  

Future Virology, Vol. 6, Iss. 8, 2011-08 ,pp. : 951-962

Future Medicine

Access to resources Recommend Favorite